Autologous haematopoietic stem cell transplantation promise for myasthenia gravis
Study findings in seven patients with severe myasthenia gravis support the use of autologous haematopoietic stem cell transplantation for achieving long-term remission.
Source: MedWire News - Category: Consumer Health News Tags: Neurology Source Type: news
More News: Brain | Health | Myasthenia Gravis | Neurology | Stem Cell Therapy | Stem Cells | Study | Transplants